Impact on Survival and Toxicity by Duration of Weight Extremes During Treatment for Pediatric Acute Lymphoblastic Leukemia: A Report From the Children's Oncology GroupEtan Orgel, David R. Freyer, Richard Sposto et al.|Journal of Clinical Oncology|2014Cited by 191
Lorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial resultsKelly C. Goldsmith, Yaël P. Mossé, Julie R. Park et al.|Nature Medicine|2023Cited by 125
Obesity is associated with residual leukemia following induction therapy for childhood B-precursor acute lymphoblastic leukemiaEtan Orgel, Steven D. Mittelman, Jonathan Tucci et al.|Blood|2014Cited by 108